HUMAN CLINICAL TRIAL FOR SAFETY OF PM-208 ANTI-SHOCK DRUG
Award details are derived from public USAspending.gov records. Not a bid recommendation.
Award details
- Award ID
- FA864924P0531
- Contractor
- PERFUSION MEDICAL, INC.
- Awarding agency
- Department of Defense
- Sub-agency / office
- Department of the Air Force
- Award amount
- $1,799,970
- Period of performance
- Jun 24, 2024 – Jan 26, 2027
- NAICS
- 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- HERNDON, VA, 201714058, USA
- Competition
- FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES · Set-aside: SMALL BUSINESS SET ASIDE - TOTAL · 84 offers
- Pricing
- FIRM FIXED PRICE
- Financial breakdown
- Current value $1,799,970 · Obligated $1,799,970 · Potential value $1,799,970 · Latest action obligation $0
Public award description
HUMAN CLINICAL TRIAL FOR SAFETY OF PM-208 ANTI-SHOCK DRUG
Find out who's winning similar federal contracts
Discover comparable awards, related contractors, and agency purchasing history.
Related intelligence
- Agency: Department of Defense
- PSC AC32 — Product Service Code AC32
- Federal market intelligence software